Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Guaifenesin D
Generic Name
Guaifenesin And Pseudoephedrine Hydrochloride
Active Ingredient
GuaifenesinCategory
Expectorant [EPC]
Variants
4
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Guaifenesin D, you must consult a qualified healthcare professional.
| 600 mg/1 | TABLET, EXTENDED RELEASE | ORAL | 70000-0580 |
Detailed information about Guaifenesin D
Guaifenesin is a widely used expectorant medication designed to help clear mucus from the respiratory tract. It belongs to a class of drugs that reduce the viscosity of secretions, making coughs more productive.
For adults and adolescents 12 years of age and older, the standard dosing for guaifenesin depends on the formulation used.
Pediatric dosing must be calculated carefully based on the child's age. The FDA and manufacturers generally provide the following guidelines:
For extended-release products, use is typically restricted to children 12 years and older unless a specific pediatric ER product is available and labeled for younger ages.
Guaifenesin is primarily excreted by the kidneys. While specific dosage adjustments are not typically required for mild renal impairment, patients with moderate to severe kidney disease should use guaifenesin with caution. There is a theoretical risk of metabolite accumulation, and in rare cases of extremely high doses, a risk of kidney stones (nephrolithiasis).
Because guaifenesin is metabolized in the liver, patients with severe hepatic impairment should consult their doctor before use. However, for standard short-term use, no specific dose adjustments are currently mandated in the clinical literature.
Elderly patients may be more sensitive to the side effects of medications. While no specific dose reduction is required for guaifenesin based on age alone, healthcare providers often recommend starting at the lower end of the dosing range, especially if the patient has age-related declines in renal function or is taking multiple other medications.
To achieve the best results and minimize side effects, follow these instructions:
If you are taking guaifenesin on a regular schedule and miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular timing. Never take two doses at once to make up for a missed one.
An acute overdose of guaifenesin is rarely life-threatening but can cause significant discomfort.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or the frequency of use without medical guidance. If your cough lasts more than 7 days, returns, or is accompanied by fever, rash, or persistent headache, consult a doctor.
Guaifenesin is generally well-tolerated when used at recommended dosages. However, some patients may experience mild adverse effects. The most common side effects involve the gastrointestinal system and the central nervous system:
Guaifenesin is a safe and effective expectorant for most people, but certain precautions must be observed to ensure its proper use. The most critical safety point is that guaifenesin is intended for the relief of a productive cough (a cough that produces mucus). It is not effective for a dry, hacking cough caused by smoking, asthma, or emphysema. Using guaifenesin for these conditions without medical advice can delay the diagnosis of a serious respiratory issue.
There are currently no FDA black box warnings for Guaifenesin. It has a long history of safe use in both adult and pediatric populations when administered at recommended dosages.
Guaifenesin itself does not have any absolute contraindications with other drugs that result in life-threatening interactions. However, the primary concern lies in combination products. Many OTC medications contain guaifenesin along with other active ingredients like dextromethorphan (an antitussive) or pseudoephedrine (a decongestant).
There are very few absolute contraindications for guaifenesin, which contributes to its status as a widely available over-the-counter medication. However, it must NEVER be used in the following circumstances:
Guaifenesin is categorized by the FDA under the old Pregnancy Category C. This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in humans.
It is not known whether guaifenesin is excreted in human milk. Because the drug has a very short half-life (1 hour) and low protein binding, the amount a nursing infant would be exposed to is likely very low. However, because there is a lack of definitive data, breastfeeding mothers should consult their healthcare provider. The primary concern is often not the guaifenesin itself, but other ingredients (like alcohol or decongestants) found in combination cough syrups.
Guaifenesin exerts its primary therapeutic effect as a secretolytic expectorant. It increases the volume and water content of the airway surface liquid (ASL). It is thought to act by irritating the gastric mucosa, which then triggers a vagal reflex (the gastropulmonary reflex) that stimulates efferent parasympathetic pathways to the bronchial glands. This results in an increase in the secretion of low-viscosity fluids from the serous glands in the lining of the respiratory tract.
Additionally, guaifenesin acts as an uncompetitive antagonist at N-methyl-D-aspartate (NMDA) receptors. By binding to these receptors, it may modulate excitatory neurotransmission. It also acts as an agonist at Sigma-1 receptors, which are involved in protein folding and calcium signaling in the endoplasmic reticulum. These neuropharmacological actions may contribute to its mild analgesic and muscle-relaxant properties, which are distinct from its respiratory effects.
The onset of action for immediate-release guaifenesin is rapid, with patients often noticing a change in cough productivity within 30 minutes. The duration of effect for IR formulations is approximately 4 to 6 hours, while extended-release formulations provide a sustained effect for 12 hours. Guaifenesin does not appear to suppress the cough reflex itself (unlike dextromethorphan); instead, it changes the nature of the cough to make it more effective at clearing the airways. There is no evidence of tolerance development with short-term use.
Common questions about Guaifenesin D
Guaifenesin is primarily used to relieve chest congestion caused by the common cold, infections, or allergies. It works as an expectorant, which means it helps thin and loosen the mucus in your lungs and throat. This makes it much easier to cough up the phlegm and clear your airways. It is specifically intended for a productive cough, often described as a 'wet' or 'chesty' cough. Your doctor may also recommend it for conditions like bronchitis to help manage mucus buildup.
Most people take guaifenesin without experiencing any significant side effects. However, the most commonly reported issues include mild nausea, vomiting, or stomach pain, especially if taken on an empty stomach. Some individuals may also experience dizziness or a mild headache shortly after taking a dose. These symptoms are usually temporary and go away as the medication leaves your system. If these effects persist or become bothersome, you should contact your healthcare provider for advice.
While there is no direct, dangerous interaction between guaifenesin and alcohol, it is generally best to avoid alcohol while you are sick. Alcohol can cause dehydration, which makes mucus thicker and harder to cough up, effectively working against the medication. Additionally, many liquid cough medicines contain a small amount of alcohol as an inactive ingredient, and adding more alcohol could increase the risk of dizziness. Always check the label of your specific product to see if it contains alcohol. Consult your doctor if you have concerns about alcohol consumption while on medication.
Guaifenesin is generally considered to have a low risk during pregnancy, but it should be used with caution, particularly in the first trimester. Some healthcare providers recommend avoiding it during the first 13 weeks because data on its safety during early fetal development is limited. In the second and third trimesters, it is often used when the benefits of clearing a cough outweigh the potential risks. However, you should never start any new medication while pregnant without first consulting your obstetrician or primary care physician. They can help you determine the safest option for your specific stage of pregnancy.
For immediate-release tablets or liquids, guaifenesin begins to work quite quickly, typically within 15 to 30 minutes of ingestion. You may notice that your cough becomes 'looser' or that you are able to bring up more mucus shortly after your first few doses. Extended-release versions also start working quickly but are designed to keep the medication in your system for a full 12 hours. To ensure the drug works effectively, it is crucial to drink plenty of water throughout the day. If you do not see any improvement in your congestion after a few days, consult your doctor.
Yes, you can stop taking guaifenesin at any time without needing to taper the dose. It is not a habit-forming medication and does not cause withdrawal symptoms. Most people stop taking it once their chest congestion has cleared and their cough has become manageable. However, if you stop taking it and your symptoms immediately return or get worse, it may be a sign that the underlying infection or condition has not fully resolved. In such cases, a follow-up with your healthcare provider is recommended to ensure you don't need additional treatment.
If you miss a dose of guaifenesin, take it as soon as you remember to help maintain the thinning of your mucus. However, if it is almost time for your next scheduled dose, it is better to skip the missed dose and simply take the next one at the regular time. You should never take two doses at once to 'catch up,' as this can increase the likelihood of experiencing side effects like nausea or dizziness. For extended-release tablets, it is especially important to stick to the 12-hour schedule. If you have questions about your dosing schedule, your pharmacist can provide guidance.
There is no clinical evidence to suggest that guaifenesin causes weight gain. It is intended for short-term use, and its pharmacological mechanism does not involve metabolic pathways or hormonal changes that would lead to an increase in body fat or water retention. If you notice unusual weight gain while taking a cough or cold medication, it is more likely related to other factors, such as reduced activity while you are sick or the side effects of other medications you may be taking simultaneously. Always discuss unexpected physical changes with your doctor.
Guaifenesin has very few direct drug interactions, but you must be careful when taking it with other multi-symptom cold medicines. Many OTC products already contain guaifenesin, and taking two different brands could lead to an accidental overdose. It is generally safe to take with most antibiotics, pain relievers like acetaminophen or ibuprofen, and most blood pressure medications. However, you should always inform your doctor or pharmacist of all medications you are taking, including herbal supplements. This is especially important if you are taking medications for chronic conditions like kidney disease.
Yes, guaifenesin is widely available as a generic medication in both immediate-release and extended-release forms. Generic versions are required by the FDA to have the same active ingredient, strength, and effectiveness as brand-name products like Mucinex or Robitussin. Choosing a generic can be a cost-effective way to treat your symptoms without sacrificing quality. You can find generic guaifenesin in most pharmacies, grocery stores, and online retailers. If you are unsure which generic version is right for you, your pharmacist can help you select a product that matches your needs.
Other drugs with the same active ingredient (Guaifenesin)
While extremely rare, some side effects require immediate medical intervention.
> Warning: Stop taking Guaifenesin and call your doctor immediately if you experience any of the following:
Guaifenesin is intended for short-term use (usually no more than 7 days). Long-term use is not recommended unless under the direct supervision of a physician. Potential risks of prolonged use include:
Guaifenesin is considered one of the safest OTC medications when used according to the label instructions. It does not have the high abuse potential or severe toxicity profile associated with many other respiratory medications. However, its safety is predicated on using it for the correct type of cough (productive) and for the appropriate duration.
Report any unusual symptoms to your healthcare provider. If you notice any side effects not listed here, contact your doctor or pharmacist for further guidance. You may also report side effects to the FDA at 1-800-FDA-1088.
For standard, short-term use of guaifenesin, routine laboratory monitoring (such as blood counts or liver function tests) is not required. However, if a patient is using guaifenesin off-label for chronic conditions, or if they have pre-existing renal impairment, a healthcare provider may occasionally monitor:
Guaifenesin generally does not cause significant impairment. However, because dizziness and mild drowsiness are possible side effects, you should observe how the medication affects you before driving a car or operating heavy machinery. If you feel lightheaded, avoid these activities until the sensation passes.
There is no known direct chemical interaction between guaifenesin and alcohol. However, many liquid 'cough and cold' products contain both guaifenesin and alcohol (as a solvent). Furthermore, alcohol can dehydrate the body, which counteracts the goal of guaifenesin (which is to hydrate mucus). It is generally recommended to limit alcohol intake while recovering from a respiratory infection to support the immune system and maintain hydration.
Guaifenesin does not require a tapering period. You can stop taking it as soon as your symptoms resolve. There is no risk of a withdrawal syndrome. If your symptoms do not improve after 7 days of use, you should discontinue the drug and see a doctor, as the medication is clearly not addressing the underlying cause of your cough.
> Important: Discuss all your medical conditions with your healthcare provider before starting Guaifenesin, especially if you have a persistent cough or kidney problems.
Guaifenesin can interfere with certain laboratory diagnostic tests:
For each major interaction, the mechanism usually involves either additive pharmacodynamic effects (in combination products) or interference with chemical assays in lab tests. The management strategy is typically to avoid combination products that contain redundant ingredients and to inform laboratory personnel of guaifenesin use before diagnostic testing.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those for cough and cold symptoms.
These are conditions where the use of guaifenesin requires a careful risk-benefit analysis by a healthcare professional:
There is no significant evidence of cross-sensitivity between guaifenesin and other classes of expectorants or respiratory medications. However, patients who are sensitive to guaiac-based products or certain wood resins should be monitored closely during their first few doses.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of allergies or kidney issues, before prescribing or recommending Guaifenesin.
Elderly patients (65 and older) may be at an increased risk for certain side effects:
In patients with significant renal impairment (GFR < 30 mL/min), the excretion of the inactive metabolite beta-(2-methoxyphenoxy)-lactic acid is delayed. While the metabolite is inactive, its accumulation has been theoretically linked to the rare formation of kidney stones. Patients with end-stage renal disease or those on dialysis should use guaifenesin only under close medical supervision.
Specific studies in patients with hepatic impairment are limited. However, since the liver is the primary site of metabolism, those with severe cirrhosis (Child-Pugh Class C) should be monitored for increased side effects like nausea and dizziness, which may indicate higher-than-normal plasma levels of the parent drug.
> Important: Special populations require individualized medical assessment to ensure that the benefits of guaifenesin use outweigh any potential risks.
| Parameter | Value |
|---|---|
| Bioavailability | High (Rapidly absorbed) |
| Protein Binding | Low (Not significantly bound) |
| Half-life | ~1 hour |
| Tmax | 15–30 minutes (IR); 1–2 hours (ER) |
| Metabolism | Hepatic (Oxidation/Hydroxylation) |
| Excretion | Renal (~90% as metabolites) |
Guaifenesin is the primary representative of the Expectorant class. While other agents like bromhexine or ambroxol are used in other countries, guaifenesin remains the only FDA-approved expectorant in the United States. It is often grouped with 'Mucolytics' (like acetylcysteine), but its mechanism is distinct; mucolytics chemically break down mucus bonds, while expectorants like guaifenesin increase the fluid volume to thin the mucus naturally.